Jinyu Bio-TechnologyLtd 

¥15.12
0
+¥0.66+4.56% 今天

統計

當日最高
15.45
當日最低
14.48
52週高點
19
52週低點
6.5
成交量
30,745,158
平均成交量
34,828,529
市值
16.81B
本益比
142.7
股息殖利率
0.21%
股息
0.03

即將到來

股息

0.21%股息殖利率
Jun 25
¥0.03
Jul 24
¥0.08
Jun 23
¥0.06
Jul 22
¥0.11
Jun 21
¥0.12
10年成長
-20.77%
5年成長
-24.21%
3年成長
-20.63%
1年成長
不適用

財報

23Apr預期
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
下一步
-0.01
0.02
0.06
0.09
預期EPS
不適用
實際EPS
不適用

財務

9.06%利潤率
有盈利
2019
2020
2021
2022
2023
2024
2.41B營收
217.97M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 600201.SHG 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. The company operates through three segments, such as veterinary biological products, veterinary chemical drugs, and traditional Chinese veterinary medicines. The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine influenza bivalent, porcine reproductive and respiratory syndrome, pseudorabies thermo-stable, porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 baculovirus vector, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine foot and mouth disease bivalent, porcine parvovirus, pseudorabies, haemophilus parasuis trivalent, and porcine circovirus type 2 vaccines. It also provides ruminant vaccines, such as foot and mouth disease trivalent, bovine pasteurella multocida, combined bovine viral diarrhea disease and infectious bovine rhinotracheitis, brucella gene deletion, goat pox, brucellosi, brucellosis, foot and mouth disease bivalent and type O, clostridium chauvoei, lumpy skin disease, combined ovine infectious necrotic hepatitis and braxy, and caprine infectious pleuropneumonia, as well as combined ovine braxy, struck, lamb dysentery, enterotoxaemia, and black disease and clostridium botulinum toxonosis vaccines. In addition, the company offers avian vaccines; rabies vaccines; and PCR and Elisa diagnostic kits. Further, it is involved in manufacturing and sales of veterinary chemical preparations, chemical reagents and auxiliary agents, biological drug preparations, and advanced medical equipment and instruments; biotechnology development, transfer, and consulting services; import and export of goods and technology; and provision of property management services. The company was founded in 1992 and is headquartered in Hohhot, China.
Show more...
執行長
Ms. Jing Zhang
員工
1740
國家
CN
ISIN
CNE000000Y37

上市

0 Comments

分享你的想法

FAQ

Jinyu Bio-TechnologyLtd 今天的股價是多少?
600201.SHG 目前價格為 ¥15.12 CNY,過去 24 小時上漲了 +4.56%。在圖表上更密切關注 Jinyu Bio-TechnologyLtd 股價表現。
Jinyu Bio-TechnologyLtd 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Jinyu Bio-TechnologyLtd 的股票以代號 600201.SHG 進行交易。
Jinyu Bio-TechnologyLtd 的股價在上漲嗎?
600201.SHG 股票較上週上漲 +5%,本月上漲 +1.14%,過去一年 Jinyu Bio-TechnologyLtd 上漲 +130.14%。
Jinyu Bio-TechnologyLtd 的市值是多少?
今天 Jinyu Bio-TechnologyLtd 的市值為 16.81B
Jinyu Bio-TechnologyLtd 下一次財報日期是什麼時候?
Jinyu Bio-TechnologyLtd 將於 April 23, 2026 公布下一次財報。
Jinyu Bio-TechnologyLtd 去年的營收是多少?
Jinyu Bio-TechnologyLtd 去年的營收為 2.41BCNY。
Jinyu Bio-TechnologyLtd 去年的淨利是多少?
600201.SHG 去年的淨收益為 217.97MCNY。
Jinyu Bio-TechnologyLtd 會發放股息嗎?
是的,600201.SHG 的股息每 年度 發放一次。每股最新股息為 0.03 CNY。截至今日,股息殖利率(FWD)% 為 0.21%。
Jinyu Bio-TechnologyLtd 有多少名員工?
截至 April 07, 2026,公司共有 1,740 名員工。
Jinyu Bio-TechnologyLtd 位於哪個產業?
Jinyu Bio-TechnologyLtd從事於Health Care產業。
Jinyu Bio-TechnologyLtd 何時完成拆股?
Jinyu Bio-TechnologyLtd 上次拆股發生於 June 25, 2018,比例為 1.3:1。
Jinyu Bio-TechnologyLtd 的總部在哪裡?
Jinyu Bio-TechnologyLtd 的總部位於 CN 的 Hohhot。